NEW YORK, Oct. 02, 2022 (GLOBE NEWSWIRE) — Bragar Eagel & Squire, PC, a nationally recognized shareholder rights law firm, reminds investors that class action lawsuits can be filed on behalf of shareholders of Coinbase Global, Inc. (NASDAQ: COIN), Carvana Co. (NYSE : CVNA), Kiromic BioPharma, Inc. (NASDAQ: KRBP) and LifeStance Health Group, Inc. (NASDAQ: LFST). Shareholders have until the deadlines below to petition the court to appear as lead plaintiffs. For more information on each case, see the link provided.

Coinbase Global, Inc. (NASDAQ:COIN)

Class Period: April 14, 2021 – September 21, 2022

Lead Plaintiff Deadline: October 3, 2022

Coinbase, a Delaware company, is one of the world’s largest crypto asset exchanges. Coinbase’s common stock is traded on the NASDAQ in the United States under the ticker symbol “COIN.”

The class action period will begin on April 14, 2021, coinciding with the initial listing of the Company’s common stock on NASDAQ (the “Direct Listing”). The registration statement and prospectus filed in connection with the Direct Listing (collectively, the “Listing Documents”) included a letter from Defendant Brian Armstrong — the Company’s co-founder, chief executive officer and chairman — in which Armstrong announced Coinbase’s commitment to upholding customer trust . Defendant Armstrong also stressed the company’s commitment to compliance, stating that “[f]from the beginning [the company] decided to focus on compliance, proactively reaching out to regulators to be an educational resource, and acquiring licenses even before they were needed.” Defendants highlighted in the listing documents the ability of customers to rely on Coinbase as a crypto-asset custodians, also citing Coinbase’s ability to “support over 90 crypto-assets for trading or custody.” In addition, while the Defendants have described certain risk factors relating to the protection of client assets, they have provided no indication that…